THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (Nasdaq:RPRX) (PCX:RPRX) today announced it has hired Dr. Andre van As, M.D., Ph.D. to serve as the Company’s Chief Medical Officer and Sr. VP of Clinical and Regulatory Affairs. Dr. van As has over 40 years of medical experience, the last 16 being in the pharmaceutical industry and most recently having served in senior clinical and regulatory positions at Novartis and Quintiles. While at Novartis he was the Global Respiratory Section Head and served as Executive Director for the Xolair team that gained U.S. approval for the first monoclonal antibody for the management of severe asthma. Dr. van As has authored numerous peer reviewed scientific articles.
